Mutation-directed targeted therapy in combination with a PD-L1 inhibitor “is a promising strategy” to extend survival in patients with anaplastic thyroid cancer, according to researchers.

Risk higher for women who gained more than 10 kg weight after 35 years of age versus those with stable weight.

A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, researchers found.

Researchers found that the prices of cancer drugs in the US increased post-launch, but there was no such increase for non-cancer drugs.

Equecabtagene autoleucel produced “remarkable” responses in patients whose disease progressed after prior BCMA CAR T-cell therapy, researchers reported.

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Results of a retrospective study of a racially diverse population demonstrated positive outcomes for patients with NSCLC who experience irAEs when treated with immune checkpoint inhibitors.

The predictive model demonstrated an 8-year cumulative incidence of TKI failure in the training set of 10% in the low-risk group, 34% in the intermediate risk, and 69% in the high-risk. In the ...

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM.

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

Targeted, culturally adapted clinical and public health interventions are needed to narrow disparities in cancer mortality,” researchers concluded.

An analysis of the clinical utility of the Hematotox-Score demonstrated the tool is predictive of hematologic toxicity in patients undergoing CAR-T therapy, but is not predictive of mortality.